Regulatory News Service

• La Rochelle, July 3, 2023 (17:40 CEST) – Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member.
• Charlotte JEZEQUEL joined the Valbiotis team as Director of Human Relations on March 13, with the aim of supporting the company as it embarks on its transition to a new commercial phase.
• As a member of the Valbiotis Executive Committee, I will be committed to continuing to drive forward the company's promising future, while maintaining a stimulating and fulfilling working environment for everyone", says Charlotte JEZEQUEL, Director of Human Relations and Valbiotis Executive Committee member.
• Laurent LÉVY, Chairman of the Nanobiotix Executive Board and Chairman of the Valbiotis Supervisory Board, adds: "Along with the entire Supervisory Board, I am delighted to welcome Charlotte JEZEQUEL to the Valbiotis Executive Committee.

• Ghent (Belgium), 30 June 2023; bonyf NV (Mnemonic: MLBON), a leading manufacturer of oral and denture care products announces its delay in the preparation and audit of the financial statements for the 2022 financial year
  bonyf NV’s, CEO and Founder, Mr Jean-Pierre Bogaert, released today an announcement to the company’s shareholders informing them that there will be a delay in the release of the audited financial statements of the company.
• We regret to inform you that bonyf NV was not yet able to publish its audited financial statements 2022.
• We understand the importance of timely and transparent financial reporting, and as such, the audited financial statements will be available by 16 July 2023.
• Should you have any questions or require further information, please do not hesitate to contact our Investor Relations department on [email protected].

GEVELOT S.A.: Weekly report of share buyback June 21, 2023
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

• The well-established Bilendi Discuss tool has been relaunched as an even more comprehensive version to cater for all requirements of qualitative market research.
• By utilising diverse research environments, Bilendi Discuss covers a comprehensive range of applications, particularly in qualitative market research.
• With the launch of the new Bilendi Discuss platform with built-in AI features, Bilendi is thrilled to support our clients in pioneering this new era of research.
• This platform will grow the overall market research business as our clients will be able to conduct more innovative research projects, especially combining qualitative and quantitative methodologies.